Hershel Dobkin, MD
Dermatology · Bexley, OHNPI 1205330826
Payments from drug & device makers
Across 856 payments — averaging $51.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$20K
- Pfizer$6K
- Incyte Corporation$4K
- AbbVie$3K
- Johnson & Johnson$2K
- Arcutis Biotherapeutics, Inc.$1K
- plus $9K from 28 others
What the payments were for
- Consulting fees$23,36953%
- Speaking & faculty fees$2,9007%
- Food & beverage$17,29439%
- Education$5311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 38 | $20,037 |
| Pfizer | 67 | $5,653 |
| Incyte Corporation | 77 | $3,567 |
| AbbVie | 188 | $2,990 |
| Johnson & Johnson(2 entities) | 88 | $1,597 |
| Arcutis Biotherapeutics, Inc. | 59 | $1,431 |
| UCB, Inc. | 39 | $1,062 |
| Sanofi | 45 | $963 |
| Regeneron Healthcare Solutions, Inc. | 30 | $947 |
| Galderma Laboratories, L.p. | 25 | $792 |
| Novartis | 36 | $740 |
| Amgen | 19 | $604 |
| Dermavant Sciences, Inc. | 24 | $587 |
| Lilly USA, LLC | 30 | $546 |
| Medimetriks Pharmaceuticals, Inc. | 9 | $508 |
| Organon | 22 | $384 |
| Journey Medical Corporation | 6 | $305 |
| LEO Pharma Inc. | 7 | $192 |
| EPI Health, LLC | 7 | $189 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $186 |
| Sun Pharmaceutical Industries Inc. | 7 | $141 |
| Mayne Pharma Commercial LLC | 6 | $124 |
| Verrica Pharmaceuticals Inc. | 5 | $91 |
| Biofrontera Inc. | 4 | $82 |
| Bristol Myers Squibb | 1 | $80 |
| Sanofi-aventis U.S. LLC | 1 | $65 |
| Kyowa Kirin, Inc. | 3 | $57 |
| Strata Skin Sciences, Inc. | 1 | $45 |
| Genentech USA, Inc. | 2 | $35 |
| Botanix SB Inc | 1 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Convatec Inc. | 1 | $23 |
| Organogenesis Inc. | 1 | $13 |
| Janssen Scientific Affairs, LLC | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$44,094 in reported general payments places this provider in the 85th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 49 | $188,087 |
| Humira(Cf) PenAdalimumab | 11 | $149,858 |
| Tacrolimus | 21 | $3,847 |
| Fluorouracil | 27 | $1,914 |
| Clobetasol Propionate | 42 | $1,770 |
| CiclopiroxCiclopirox Olamine | 44 | $1,373 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 13 | $1,045 |
| Tretinoin | 11 | $990 |
| Ciclopirox | 25 | $945 |
| Triamcinolone Acetonide | 65 | $910 |
| Doxycycline Hyclate | 31 | $707 |
| Ketoconazole | 54 | $648 |
| Betamethasone Dipropionate | 18 | $457 |
| Montelukast Sodium | 37 | $445 |
| Clindamycin Phosphate | 16 | $358 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Bexley
- Matthew ZirwasBexley$7.4M
- Neil KormanCleveland$6M
- Jeffrey TraversDayton$4.7M
- Jennifer NashWesterville$4M
- Jessica KaffenbergerColumbus$3.2M
- Rocco SerraoDayton$3M
- Patrick ShannonBoardman$2M
- George DrewMarion$2M
- Benjamin BoguckiColumbus$2M
- Michelle ChambersColumbus$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.